BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2306744)

  • 1. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
    Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats.
    Friedman HS; Archer GE; McLendon RE; Schuster JM; Colvin OM; Guaspari A; Blum R; Savina PA; Fuchs HE; Bigner DD
    Cancer Res; 1994 Sep; 54(17):4710-4. PubMed ID: 8062269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
    Schuster JM; Friedman HS; Archer GE; Fuchs HE; McLendon RE; Colvin OM; Bigner DD
    Cancer Res; 1993 May; 53(10 Suppl):2338-43. PubMed ID: 8485721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis.
    Phillips PC; Than TT; Cork LC; Hilton J; Carson BS; Colvin OM; Grochow LB
    Cancer Res; 1992 Nov; 52(22):6168-74. PubMed ID: 1423260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.
    Zalutsky MR; McLendon RE; Garg PK; Archer GE; Schuster JM; Bigner DD
    Cancer Res; 1994 Sep; 54(17):4719-25. PubMed ID: 8062270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis.
    Nakagawa H; Yoshioka K; Miyahara E; Fukushima Y; Tamura M; Itoh K
    Mol Cancer Res; 2005 Aug; 3(8):425-33. PubMed ID: 16123138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys.
    Arndt CA; Colvin OM; Balis FM; Lester CM; Johnson G; Poplack DG
    Cancer Res; 1987 Nov; 47(22):5932-4. PubMed ID: 3664493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
    Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
    Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis.
    Kassis AI; Kirichian AM; Wang K; Semnani ES; Adelstein SJ
    Int J Radiat Biol; 2004; 80(11-12):941-6. PubMed ID: 15764406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
    Nakagawa H; Yamada M; Fukushima M; Ikenaka K
    Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats.
    Archer GE; Sampson JH; McLendon RE; Friedman AH; Colvin OM; Rose M; Sands H; McCullough W; Fuchs HE; Bigner DD; Friedman HS
    J Neurooncol; 1999; 44(3):233-41. PubMed ID: 10720203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse.
    Abernathey CD; Kooistra KL; Wilcox GL; Laws ER
    Neurosurgery; 1988 May; 22(5):877-81. PubMed ID: 2837674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of neoplastic meningitis with intrathecal temozolomide.
    Sampson JH; Archer GE; Villavicencio AT; McLendon RE; Friedman AH; Bishop WR; Bigner DD; Friedman HS
    Clin Cancer Res; 1999 May; 5(5):1183-8. PubMed ID: 10353755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
    Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
    Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
    Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
    No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
    Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
    Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
    No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.